17,261 trials
Influenza
Primary: Titers for Serum Hemagglutination Inhibition (HI) Antibodies Against 2 Strains of Influenza Disease — NA; NA; NA; NA Titer
Genotype 1 Chronic Hepatitis C
Primary: EVR (Early Virologic Response) — 79.4; 78.5 percentage of participants — p=1.000
Lymphoma · Myeloma · Leukemia
Primary: Toxicity — 5; 3; 10; 17 participants
Melanoma (Skin)
Primary: Plasma b-FGF Level Response — 34.5 percentage of participants — p=<0.001
Pulmonary Disease, Chronic Obstructive · Asthma
Primary: Trough FEV1 Response After 4 Weeks — -0.014; 0.046; 0.082; 0.109 Liter — p=0.0233
Refractory Angina
Primary: Angina Class Variation — -2.0; -1.0; -0.5; 4.0 Angina Classification — p=< 0.001
Hip Fracture · Osteoarthritis · Femur Head Necrosis
Primary: Muscle Protein Synthesis — 1.38; 0.84; 1.42; 1.36 %/d
Hodgkin's Disease · Non Hodgkin's Lymphoma · Myeloma
Primary: Disease Free Survival — 47; 23; 16 percentage of participants
Melanoma
Primary: Number of Participants With a Best Overall Response of Confirmed Complete Response (CR) or Partial Response (PR) as Assessed by the Investigator for Participants Who Had…
Sexual Dysfunction, Physiological
Primary: Persistently Elevated Serum Estradiol Level Outside the Post-menopausal Range — 0; 4 participants
Waldenstrom's Macroglobulinemia · Lymphoplasmacytic Lymphoma
Primary: Objective Response Rate — 1; 15; 2; 7 participants
Psoriasis
Primary: Proportion of Patients in the Study With Hypothalamic Pituitary Adrenal (HPA) Axis Suppression — 2; 3 participants
Rosacea · Erythema
Primary: Percentage of Participants With at Least a 2-Grade Decrease From Baseline on Both Clinician Erythema Assessment (CEA) and Subject Self-Assessment (SSA) — 13.3; 20.5…
Asthma · Perennial Allergic Rhinitis
Primary: Change in German Cockroach-Specific Serum IgE Over Time — 2.0; 2.7; 1.2 Ratio — p=0.001
Creutzfeldt-Jakob Disease
Primary: Primary Survival — 19; 13 participants — p=0.43